Gestational diabetes

• Research type

  Research Study

• Full title

  Gestational diabetes

• IRAS ID

  210839

• Contact name

  Pat Day

• Contact email

  pat.day@.shu.ac.uk

• Sponsor organisation

  Sheffield Hallam University

• Duration of Study in the UK

  0 years, 7 months, 0 days

• Research summary

  Question: How can health professionals enable women with gestational diabetes to achieve a life without diabetes?\nGestational diabetes poses a serious health threat both to the women who develop it and their unborn babies. These threats can include miscarriage, pre-eclampsia, (high blood pressure and protein in the urine) and a preterm labour. Stillbirth, congenital malformations, larger babies, birth injury, perinatal mortality (foetal deaths after 24 completed weeks of gestation and death before 7 completed days), and hypoglycaemia, (low blood sugars) are also more common in babies born to women with diabetes. It increases the risk of overweight and obesity in their children in later life. 1 in 3 women who develop gestational diabetes during pregnancy will go on to develop type 2 diabetes within 5 years. The incidence of diabetes is increasing. As a result, diabetes is, and will continue to be a financial burden upon the national health service. \nThe research will consider the experiences of 4 women who developed gestational diabetes. Participants will be recruited from Rotherham Hospital obstetric department. A semi structured interview of approximately one hour will be conducted in order to ascertain the experience that the women had of their diagnosis. It will also seek to identify what action the women took within their lives in terms of adopting a healthier diet and lifestyle.\nIt is proposed that a strategy of early intervention and prevention could reduce the number of women who might otherwise develop type 2 diabetes. Health professionals can play a vital role in contributing to a healthier outcome for women and their families. It is expected that the research outcomes of the project will be able to inform practice. Any decrease in the development of diabetes will reduce the financial burden upon the health service.\nThere will be no cost implications for the research project.\n\n\n

• REC name

  North West - Preston Research Ethics Committee

• REC reference

  16/NW/0782

• Date of REC Opinion

  3 Nov 2016

• REC opinion

  Favourable Opinion